Publications by authors named "Kent Riley"

Claim this Profile
E
Evaluation of TK1 targeting carboranyl thymidine analogs as potential delivery agents for neutron capture therapy of brain tumors.
Rolf F Barth, Weilian Yang, Robin J Nakkula, Youngjoo Byun, Werner Tjarks, Kent J Riley

Appl Radiat Isot· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Energy- and time-resolved detection of prompt gamma-rays for proton range verification.
Joost M Verburg, Kent Riley, Thomas Bortfeld, Joao Seco

Phys Med Biol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer.
Rolf F Barth, M Graca H Vicente, Otto K Harling, W S Kiger, Kent J Riley

Radiat Oncol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of intracerebral delivery of carboplatin and photon irradiation with an optimized regimen for boron neutron capture therapy of the F98 rat glioma.
Rolf F Barth, Weilian Yang, Tianyao Huo, Kent J Riley, Peter J Binns

Appl Radiat Isot· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Convection enhanced delivery of carboranylporphyrins for neutron capture therapy of brain tumors.
Shinji Kawabata, Weilian Yang, Rolf F Barth, Gong Wu, Tianyao Huo, Kent J Riley

J Neurooncol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Convection enhanced delivery of boronated EGF as a molecular targeting agent for neutron capture therapy of brain tumors.
Weilian Yang, Rolf F Barth, Gong Wu, Tianyao Huo, Werner Tjarks, Kent J Riley

J Neurooncol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thymidine kinase 1 as a molecular target for boron neutron capture therapy of brain tumors.
Rolf F Barth, Weilian Yang, Gong Wu, Michele Swindall, Youngjoo Byun, Kent J Riley

Proc Natl Acad Sci U S A· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional and histological changes in rat lung after boron neutron capture therapy.
Jingli Liu Kiger, W S Kiger, Kent J Riley, Peter J Binns, Hemant Patel

Radiat Res· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular targeting and treatment of composite EGFR and EGFRvIII-positive gliomas using boronated monoclonal antibodies.
Weilian Yang, Gong Wu, Rolf F Barth, Michele R Swindall, Achintya K Bandyopadhyaya, Kent J Riley

Clin Cancer Res· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No significant endothelial apoptosis in the radiation-induced gastrointestinal syndrome.
Bradley W Schuller, Arlin B Rogers, Kathleen S Cormier, Kent J Riley, Peter J Binns

Int J Radiat Oncol Biol Phys· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved dose targeting for a clinical epithermal neutron capture beam using optional (6)Li filtration.
Peter J Binns, Kent J Riley, Yakov Ostrovsky, Wei Gao, J Raymond Albritton

Int J Radiat Oncol Biol Phys· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular targeting and treatment of an epidermal growth factor receptor-positive glioma using boronated cetuximab.
Gong Wu, Weilian Yang, Rolf F Barth, Shinji Kawabata, Michele Swindall, Kent J Riley

Clin Cancer Res· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular targeting and treatment of EGFRvIII-positive gliomas using boronated monoclonal antibody L8A4.
Weilian Yang, Rolf F Barth, Gong Wu, Shinji Kawabata, Thomas J Sferra, Kent J Riley

Clin Cancer Res· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective irradiation of the vascular endothelium has no effect on the survival of murine intestinal crypt stem cells.
Bradley W Schuller, Peter J Binns, Kent J Riley, Ling Ma, M Frederick Hawthorne

Proc Natl Acad Sci U S A· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The MIT user center for neutron capture therapy research.
Otto K Harling, Kent J Riley, Peter J Binns, Hemant Patel, Jeffrey A Coderre

Radiat Res· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutron capture therapy of epidermal growth factor (+) gliomas using boronated cetuximab (IMC-C225) as a delivery agent.
Rolf F Barth, Gong Wu, Weilian Yang, Peter J Binns, Kent J Riley

Appl Radiat Isot· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Boronated epidermal growth factor as a delivery agent for neutron capture therapy of EGF receptor positive gliomas.
Weilian Yang, Rolf F Barth, Gong Wu, Achintya K Bandyopadhyaya, B T S Thirumamagal, Kent Riley

Appl Radiat Isot· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Boron neutron capture therapy: cellular targeting of high linear energy transfer radiation.
Jeffrey A Coderre, Julie C Turcotte, Kent J Riley, Peter J Binns, Otto K Harling

Technol Cancer Res Treat· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microdosimetric intercomparison of BNCT beams at BNL and MIT.
Jay Burmeister, Kent Riley, Jeffrey A Coderre, Otto K Harling, Ruimei Ma

Med Phys· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fission reactor neutron sources for neutron capture therapy--a critical review.
Otto K Harling, Kent J Riley

J Neurooncol· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A critical examination of the results from the Harvard-MIT NCT program phase I clinical trial of neutron capture therapy for intracranial disease.
Paul M Busse, Otto K Harling, Matthew R Palmer, W S Kiger, Jody Kaplan, Kent J Riley

J Neurooncol· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment planning and dosimetry for the Harvard-MIT Phase I clinical trial of cranial neutron capture therapy.
Matthew R Palmer, J Timothy Goorley, W S Kiger, Paul M Busse, Kent J Riley

Int J Radiat Oncol Biol Phys· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A physical dosimetry intercomparison for BNCT.
Kent J Riley, Peter J Binns, Dennis D Greenberg, Otto K Harling

Med Phys· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis